甘李药业股份有限公司 关于公司持股5%以上股东部分股份解押的公告

Core Points - Beijing Xute Hongda Technology Co., Ltd. holds 32,073,734 shares of Ganli Pharmaceutical Co., Ltd., accounting for 5.37% of the total share capital. Recently, Xute Hongda completed the release of 600,000 shares from pledge, reducing the total pledged shares to 23,410,000, which is 72.99% of its holdings and 3.92% of the total share capital [1] - The controlling shareholder, Mr. Gan Zhongru, and Xute Hongda together hold 237,717,491 shares, representing 39.80% of the total share capital. After the release of the pledge, the total pledged shares amount to 23,410,000, which is 9.85% of their holdings and 3.92% of the total share capital [1] Pledge Release Situation - The announcement details the situation regarding the release of share pledges by the shareholders [1] Cumulative Pledged Shares Situation - As of the announcement date, the cumulative pledged shares by the shareholders and their concerted actions are outlined [1] Impact of Pledged Shares on the Company - The 5% shareholder, Xute Hongda, has a good credit status and sufficient repayment capability. The pledged shares currently do not pose a risk of forced liquidation or transfer, indicating that the pledge risk is manageable and will not materially affect the company's operations [1]